Dr. Anthony Fauci, National Institute of Allergy and Infectious Diseases Director, to Give Keynote
Noted AIDS researcher and immunologist Anthony S. Fauci will deliver the keynote address at the 2011 commencement ceremony for Albert Einstein College of Medicine of Yeshiva University. Dr. Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH), will speak at Einstein’s graduation, which takes place Wednesday, June 1, 2011 at 3 p.m. at Lincoln Center’s Avery Fisher Hall.
Director of NIAID since 1984, Dr. Fauci oversees basic and applied research to prevent, diagnose, and treat infectious diseases such as HIV/AIDS and other sexually transmitted infections, influenza, tuberculosis, and malaria, as well as illness from potential agents of bioterrorism. NIAID also supports research on transplantation and immune-related illnesses, including autoimmune disorders, asthma and allergies. In addition to HIV/AIDS, Dr. Fauci also advises senior administration officials on initiatives to bolster medical and public health preparedness against emerging infectious disease threats such as pandemic influenza.
In his commencement address, Dr. Fauci will highlight the constant change inherent in medicine, which is evolving as fast as the frontier of biomedical science advances. His talk, “The Perpetual Student and the Changing Landscape of Medicine,” will address how this ongoing evolution of science is both demanding and exciting, encouraging clinicians and researchers to learn throughout their entire career. While keeping abreast of the latest research is important, Dr. Fauci will also emphasize the need for physicians to keep the enduring principles of patient care at the forefront of their minds.
“Dr. Fauci is an extraordinary physician/scientist, research administrator and public servant,” said Allen M. Spiegel, M.D., the Marilyn and Stanley M. Katz Dean. “He exemplifies the professional and personal characteristics our graduates should strive to emulate.” Read full article here…